Literature DB >> 17457396

[Subarachnoid haemorrhage--diagnosis and management].

Søren Jacob Bakke1, Karl-Fredrik Lindegaard.   

Abstract

INTRODUCTION: Subarachnoid haemorrhage (SAH) causes 3% of all strokes and is caused by a ruptured cerebral aneurysm in four of five cases. This review article presents an update of knowledge on symptoms, diagnosis and management of SAH.
MATERIAL AND METHODS: This article is based on selected literature and the authors' clinical experience. RESULTS AND
INTERPRETATION: The mortality of SAH is approximately 50% and one out of three survivors have permanent disabling neurological symptoms. Patients with suspected or diagnosed SAH need urgent examination and treatment. A large randomised multicentre study (International Subarachnoid Aneurysm Trial) suggests that endovascular repair with coiling may be less traumatic than microsurgery. Not all patients are suitable for endovascular treatment, despite new tools like balloon- and stent-assisted coiling. Centres that treat patients with SAH should have both methods available at all hours. The management of these patients involves advanced neuro-intensive care, and co-operation between neurosurgeons, neuroradiologists and neuroanestesiologists.

Entities:  

Mesh:

Year:  2007        PMID: 17457396

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  3 in total

1.  Vascular interventional neuroradiology in a country with a small and scattered population. Twenty years' experience in norway.

Authors:  Per Hj Nakstad
Journal:  Interv Neuroradiol       Date:  2008-05-12       Impact factor: 1.610

2.  Bioinformatic analysis of gene expression profiling of intracranial aneurysm.

Authors:  Lijuan Bo; Bo Wei; Zhanfeng Wang; Chaohui Li; Zheng Gao; Zhuang Miao
Journal:  Mol Med Rep       Date:  2017-12-29       Impact factor: 2.952

3.  Improper monitoring and deviations from physiologic treatment goals in patients with brain injury in the early phases of emergency care.

Authors:  Siri Kojen Andersen; Ragnhild Hustveit; Erlend Frøland; Oddvar Uleberg; Andreas Krüger; Pål Klepstad; Trond Nordseth
Journal:  J Clin Monit Comput       Date:  2020-01-14       Impact factor: 2.502

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.